Review on Angiogenesis Modulation by Natural Compounds as Therapeutic Potential and Mechanisms

Jegathambigai Rameshwar Naidu ^1* , Sasidharan Sreenivasan ², Sakina Ruhi 1, Hana W. Jun Chen ¹, Sanjith Rameshwar Naidu ¹, Danish Khan ³, Thin Thin Aung ¹, Mya Mya Thwin ¹, Husni Ahmed Al-Goshae ¹, Subramanian Rammohan ¹

Compounds derived from plants that have antiangiogenic effects could be used in the development of drugs that target this stage of angiogenesis.

Abstract

Angiogenesis is induced when there is any imbalance in the equilibrium due to either up regulation of pro-angiogenic factors or down regulation of anti-angiogenic mediators. Recent interest in identifying and modulating antiangiogenic pathways and antiangiogenic drug development has added advantage for therapeutic purposes. Many naturally occurring compounds have been indicated as inhibitors of tumor specific angiogenesis. This review was covers the topics including pathophysiology of angiogenesis, angiogenesis modulating compounds from plants, antiangiogenic potential of culinary herbs.  The anti-angiogenic potential of the plants may be due to the prese.nce of terpenoids and flavonoids. The molecular mechanisms responsible for the antiangiogenic activity may be associated with inhibition of several steps of angiogenesis including proliferation, migration and tube formation of vascular endothelial cells. Since there is a close relationship between tumor growth and angiogenesis mechanism, various anti-angiogenic compounds for use in cancer treatment have been studied. Angiogenic modulators would be an ideal choice for future chemotherapeutics.

Keywords: Angiogenesis, Angiogenic modulators, Therapeutic potential, Medicinal plants

References

Avramis, I.A. et al. (2001). Taxotere and Vincristine inhibit the secretion of the angiogenesis inducing vascular endothelial growth factor(VEGF) by wild-type drug-resistant human leukemia T-cell lines. Anticancer Res. 21, 2281-2286.

Baumgartner, I., Pieczek, A., Manor, O., Blair, R., Kearney, M., Walsh, K., Isner, J.M., (1998). Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limB ischemia.Circulation 97 (12), 1114-1123.

https://doi.org/10.1161/01.CIR.97.12.1114

Bergers and Benjamin, 2003; Berger, G., Benjamin, L.E. (2003). Tumorigenesis and the angiogenic switch. Nat.Rev Cancer, 3:401-410.

https://doi.org/10.1038/nrc1093

Brown et al., 1992: Brown, L.F., Yeo, K.T., Berse B. (1992). Expression of vascular permeability factor (VEGF) by epidermal keratinocytes during wound healing. J Exp Med, 176:1375-1379.

https://doi.org/10.1084/jem.176.5.1375

Distler et al., 2003)- Distler, J.H.W., Hirth, A., Kurowska-Stolarska, M., Gay, R.E., Gay, S., Distler, O. (2003) Angiogenic and angiostatic factors in the molecular control of angiogenesis. Q J Nucl Med ;47:149-61.

Folkman J., Klagsbrun M. (1987). Angiogenic factor. Science 253:442-447.

https://doi.org/10.1126/science.2432664

Gargett CE., Rogers AW. (2001). Human endometrial angiogenesis. Reproduction, 121:181-186.

https://doi.org/10.1530/rep.0.1210181

Haitoa et al., Haitao Luo., Gary, O. Rankin., Lingzhi Liu., Matthew, K. Daddysman., Bing-Hua Jiang and Yi Charlie Chen. (2009). Kaempferol Inhibits Angiogenesis and VEGF Expression ThroughBoth HIF Dependent and Independent Pathways in Human Ovarian, Cancer Cells. Nutr Cancer. 61(4): 554-563.

https://doi.org/10.1080/01635580802666281

Horvath, K.A., Cohn, L.H., Cooley, D.A., Crew, J.R., Frazier, O.H., Griffith, B.P., Kadipasaoglu, K., Lansing, A., Mannting, F., March, R., Mirhoseini, M.R., Smith, C. (1997). Transmyocardial laser revascularization: results of a multicenter trial with transmyocardial laser revascularization used as sole therapy for end-stage coronary artery disease. The Journal of Thoracic and Cardiovascular Surgery 113, 645-653.

https://doi.org/10.1016/S0022-5223(97)70221-6

Johnson Johnson, H., Bailey, H., Mukhtar, H. (2010). Green tea polyphenols for prostate cancer chemoprevention: A translational perspective J.J. , Phytomedicine 17 .

https://doi.org/10.1016/j.phymed.2009.09.011

Lamy, S., Blanchette, M., Michaud-Levesque, J., Lafleur, R., Durocher, Y., Moghrabi, A., Barrette, S., Gingras, D., Beliveau, R. (2006). Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis ;27:989-96.

https://doi.org/10.1093/carcin/bgi279

Leyon, P.V., Kuttan, G. (2003). Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumor specific angiogenesis. J Exp Clin Cancer Res ;22:77-83.

Lossordo et al., 2005. Losordo, D.W., Vale, P.R., Symes, J.F., Dunnington, C.H., Esakof, D.D., Maysky, M., Ashare, A.B., Lathi, K., Isner, J.M., (1998). Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804.

https://doi.org/10.1161/01.CIR.98.25.2800

Mann, G. E., Rowland, D. J., Li, F., Winter, Y. L., de Patricia, R., and Siow, C. M. (2007). Activation of endothelial nitric oxide synthase by dietary isoflavones: Role of NO in Nrf2-mediated antioxidant gene expression. Cardiovascular Research, 75, 261−274.

https://doi.org/10.1016/j.cardiores.2007.04.004

Manoj, G. Tyagi., A. Babu Vimalanathan and Gope Assudani.( 2010). Pathophysiology of Angiogenesis and novel angiomodulators from plant sources for therapeutic purpose. Journal of phytology. 2 (11): 13-24.

Ming-Fang He., Lin Liua.,Wei Ge., Pang-Chui Shaw., Renwang Jiang. Li-WhaWu., Paul Pui-Hay But. (2009). Antiangiogenic activity of Tripterygium wilfordii and its terpenoids. Journal of Ethnopharmacology 121-61

https://doi.org/10.1016/j.jep.2008.09.033

Oak, M.H., El Bedoui, J., Schini-Kerth, V.B. (2005). Antiangiogenic properties of natural polyphenols from red wine and green tea. J Nutr Biochem;16:1-8.

https://doi.org/10.1016/j.jnutbio.2004.09.004

Peter, Bu¨ chler, Howard, A. Reber, Markus W. Bu¨ chler, Helmut Friess, Robert S. Lavey, Oscar J. Hines, M.D. (2004). Antiangiogenic Activity of Genisteinin Pancreatic Carcinoma Cells Is Mediated by the Inhibition of Hypoxia-Inducible Factor-1 and the Downregulation of VEGF Gene Expression. Cancer January 1, / Volume 100 / Number 1.

https://doi.org/10.1002/cncr.11873

Pugh CW, Ratcliffe PJ. (2003). Regulation of angiogenesis by hypoxia: role of HIF system. Nat Med;9:677-84.

https://doi.org/10.1038/nm0603-677

Raghu K. (2003). Basement membrane's structure assembly and role in tumor angiogenesis. Nat. Med 3:442-433.

https://doi.org/10.1038/nrc1094

Rosengart, T.K., Lee, L.Y., Patel, S.R., Sanborn, T.A., Parikh, M., Bergman, G.W., Hachamovitch, R., Szulc, M., Kligfield, P.D., Okin, P.M., Hahn, R.T., Devereux, R.B., Post, M.R., Hackett, N.R., Foster, T., Grasso, T.M., Lesser, M.L., Isom, O.W., Crystal, R.G. (1999). Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation. Aug 3 100 (5), 468-474.

https://doi.org/10.1161/01.CIR.100.5.468

Shirley, Kuhnena., Priscilla, Maria., Menel, Lemosa., Luciano, Henrique, Campestrinia., Juliana, Bernardi, Ogliaria., Paulo, Fernando Diasb., Marcelo, Maraschina. (2009). Antiangiogenic properties of carotenoids: A potential role of maize as functional food. Journal functional foods 1: 284-290.

https://doi.org/10.1016/j.jff.2009.04.001

Sunila, E. S., Kuttan, G., (2006). Piper longum inhibits VEGF and pro-inflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice. Int Immunopharmacol ;6:733-41.

https://doi.org/10.1016/j.intimp.2005.10.013

Tai-Ping Fan., Ju-Ching Yeh., Kar Wah Leung Y.K. Yue and Ricky N. N Wong.(2006). Angiogenesis: from plants to blood vessels. Trend in pharmacological sciences. Vol 27 No. 6.

https://doi.org/10.1016/j.tips.2006.04.006

Tan, W.F., Lin, L.P., Li, M.H., Zhang, Y.X., Tong, Y.G., Xiao, D., Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol ;459:255-62.

https://doi.org/10.1016/S0014-2999(02)02848-0

Tonnesen, M.G., Feng, X., Clark, R.A.F. (2000). Angiogenesis in wound healing. J Investig Dermatol Symp Proc, 5:40- 46.

https://doi.org/10.1046/j.1087-0024.2000.00014.x

Walsh, D.A., Pearson, C.I. (2001). Angiogenesis in the pathogenesis of inflammatory joint and lung diseases. Arthritis Res ;31: 147-53.

https://doi.org/10.1186/ar292

Wang Shanshan., Zhengui, Zheng., Yinqi, Weng., Yijun, Yuc., Daifu, Zhanga., Weihu, Fanb., Ruihong, Daib,, Zhibi, Hua. (2004). Anti-angiogenesis activity of Chinese medicinal herbal extracts. Life Sciences 74, 2467-2478.

https://doi.org/10.1016/j.lfs.2003.03.005

Yance, D.R., Saga, S.M. (2006). Targeting angiogenesis with integrative cancer therapies. Integr Cancer Ther;5:9-29.

https://doi.org/10.1177/1534735405285562